An Act relative to pharmacists as healthcare providers

This bill allows certified pharmacists in Massachusetts to test for, screen, and initiate treatment for specific health conditions - including influenza, strep infections, COVID-19, HIV (including PrEP/PEP), and others approved by the pharmacy board - under a statewide protocol. Pharmacists may delegate administrative tasks to pharmacy technicians and use CLIA-waived tests, with specific guidance for positive COVID-19 cases requiring patient advice and reporting. The law mandates that insurance companies reimburse pharmacists at standard rates for these services, prohibiting denial of coverage for certified pharmacists providing these treatments within their scope. It directly affects pharmacists, patients seeking these services, and healthcare insurers across the state.